View in EDS

Inhaled pirfenidone solution (AP01) for IPF: a randomised, open-label, dose-response trial.

Saved in:
Bibliographic Details
Title: Inhaled pirfenidone solution (AP01) for IPF: a randomised, open-label, dose-response trial.
Authors: West A; Guy's and St Thomas' Hospital, London, UK., Chaudhuri N; University of Ulster, Magee Campus, Londonderry, UK., Barczyk A; Department of Pneumonology, Medical University of Silesia, Katowice, Slaskie, Poland., Wilsher ML; Respiratory Services, Auckland District Health Board, Auckland, New Zealand., Hopkins P; The Prince Charles Hospital, Brisbane, Queensland, Australia., Glaspole I; Department of Respiratory Medicine, Alfred Hospital, Melbourne, Victoria, Australia., Corte TJ; Department of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.; Department of Respiratory Medicine, Royal Brompton Hospital, London, UK., Šterclová M; Department of Respiratory Medicine, Thomayer Hospital, Praha, Praha, Czech Republic., Veale A; Department of Respiratory Medicine, Queen Elizabeth Hospital, Woodville South, South Australia, Australia., Jassem E; Gdanski Uniwersytet Medyczny, Gdansk, Poland., Wijsenbeek MS; Department of Respiratory Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands., Grainge C; Hunter Medical Research Institute, University of Newcastle, New Castle, New South Wales, Australia., Piotrowski W; Department of Pneumonology and Allergy, Medical University of Lodz, Lodz, Lodzkie, Poland., Raghu G; CENTER for Interstitial Lung Diseases, University of Washington, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA., Shaffer ML; Avalyn Pharma Inc, Seattle, Washington, USA., Nair D; Avalyn Pharma Inc, Seattle, Washington, USA., Freeman L; Avalyn Pharma Inc, Seattle, Washington, USA., Otto K; Avalyn Pharma Inc, Seattle, Washington, USA., Montgomery AB; Avalyn Pharma Inc, Seattle, Washington, USA bruce.montgomerymd@gmail.com.
Source: Thorax [Thorax] 2023 Sep; Vol. 78 (9), pp. 882-889. Date of Electronic Publication: 2023 Mar 22.
Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: British Medical Assn Country of Publication: England NLM ID: 0417353 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-3296 (Electronic) Linking ISSN: 00406376 NLM ISO Abbreviation: Thorax Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36948586
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Inhaled pirfenidone solution (AP01) for IPF: a randomised, open-label, dose-response trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22West+A%22">West A</searchLink>; Guy's and St Thomas' Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Chaudhuri+N%22">Chaudhuri N</searchLink>; University of Ulster, Magee Campus, Londonderry, UK.<br /><searchLink fieldCode="AU" term="%22Barczyk+A%22">Barczyk A</searchLink>; Department of Pneumonology, Medical University of Silesia, Katowice, Slaskie, Poland.<br /><searchLink fieldCode="AU" term="%22Wilsher+ML%22">Wilsher ML</searchLink>; Respiratory Services, Auckland District Health Board, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Hopkins+P%22">Hopkins P</searchLink>; The Prince Charles Hospital, Brisbane, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Glaspole+I%22">Glaspole I</searchLink>; Department of Respiratory Medicine, Alfred Hospital, Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Corte+TJ%22">Corte TJ</searchLink>; Department of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.; Department of Respiratory Medicine, Royal Brompton Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Šterclová+M%22">Šterclová M</searchLink>; Department of Respiratory Medicine, Thomayer Hospital, Praha, Praha, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Veale+A%22">Veale A</searchLink>; Department of Respiratory Medicine, Queen Elizabeth Hospital, Woodville South, South Australia, Australia.<br /><searchLink fieldCode="AU" term="%22Jassem+E%22">Jassem E</searchLink>; Gdanski Uniwersytet Medyczny, Gdansk, Poland.<br /><searchLink fieldCode="AU" term="%22Wijsenbeek+MS%22">Wijsenbeek MS</searchLink>; Department of Respiratory Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Grainge+C%22">Grainge C</searchLink>; Hunter Medical Research Institute, University of Newcastle, New Castle, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Piotrowski+W%22">Piotrowski W</searchLink>; Department of Pneumonology and Allergy, Medical University of Lodz, Lodz, Lodzkie, Poland.<br /><searchLink fieldCode="AU" term="%22Raghu+G%22">Raghu G</searchLink>; CENTER for Interstitial Lung Diseases, University of Washington, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Shaffer+ML%22">Shaffer ML</searchLink>; Avalyn Pharma Inc, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Nair+D%22">Nair D</searchLink>; Avalyn Pharma Inc, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Freeman+L%22">Freeman L</searchLink>; Avalyn Pharma Inc, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Otto+K%22">Otto K</searchLink>; Avalyn Pharma Inc, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Montgomery+AB%22">Montgomery AB</searchLink>; Avalyn Pharma Inc, Seattle, Washington, USA bruce.montgomerymd@gmail.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220417353%22">Thorax</searchLink> [Thorax] 2023 Sep; Vol. 78 (9), pp. 882-889. <i>Date of Electronic Publication: </i>2023 Mar 22.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22British+Medical+Assn%22">British Medical Assn </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0417353 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1468-3296 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200406376%22">00406376 </searchLink><i>NLM ISO Abbreviation: </i>Thorax <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36948586
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/thorax-2022-219391
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 882
    Titles:
      – TitleFull: Inhaled pirfenidone solution (AP01) for IPF: a randomised, open-label, dose-response trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: West A
      – PersonEntity:
          Name:
            NameFull: Chaudhuri N
      – PersonEntity:
          Name:
            NameFull: Barczyk A
      – PersonEntity:
          Name:
            NameFull: Wilsher ML
      – PersonEntity:
          Name:
            NameFull: Hopkins P
      – PersonEntity:
          Name:
            NameFull: Glaspole I
      – PersonEntity:
          Name:
            NameFull: Corte TJ
      – PersonEntity:
          Name:
            NameFull: Šterclová M
      – PersonEntity:
          Name:
            NameFull: Veale A
      – PersonEntity:
          Name:
            NameFull: Jassem E
      – PersonEntity:
          Name:
            NameFull: Wijsenbeek MS
      – PersonEntity:
          Name:
            NameFull: Grainge C
      – PersonEntity:
          Name:
            NameFull: Piotrowski W
      – PersonEntity:
          Name:
            NameFull: Raghu G
      – PersonEntity:
          Name:
            NameFull: Shaffer ML
      – PersonEntity:
          Name:
            NameFull: Nair D
      – PersonEntity:
          Name:
            NameFull: Freeman L
      – PersonEntity:
          Name:
            NameFull: Otto K
      – PersonEntity:
          Name:
            NameFull: Montgomery AB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2023 Sep
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1468-3296
          Numbering:
            – Type: volume
              Value: 78
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Thorax
              Type: main
ResultId 1